Detalhe da pesquisa
1.
Lisocabtagene maraleucel for patients with relapsed or refractory large B-cell lymphomas (TRANSCEND NHL 001): a multicentre seamless design study.
Lancet
; 396(10254): 839-852, 2020 09 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-32888407
2.
Mutations affecting the SAND domain of DEAF1 cause intellectual disability with severe speech impairment and behavioral problems.
Am J Hum Genet
; 94(5): 649-61, 2014 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-24726472
3.
Cellular determinants for preclinical activity of a novel CD33/CD3 bispecific T-cell engager (BiTE) antibody, AMG 330, against human AML.
Blood
; 123(4): 554-61, 2014 Jan 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-24311721
4.
Exploration of Tumor Biopsy Gene Signatures to Understand the Role of the Tumor Microenvironment in Outcomes to Lisocabtagene Maraleucel.
Mol Cancer Ther
; 22(3): 406-418, 2023 03 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36595660
5.
Immunomodulation by durvalumab and pomalidomide in patients with relapsed/refractory multiple myeloma.
Sci Rep
; 11(1): 16460, 2021 08 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34385543
6.
Efficacy and Safety of Durvalumab Combined with Daratumumab in Daratumumab-Refractory Multiple Myeloma Patients.
Cancers (Basel)
; 13(10)2021 May 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-34070044
7.
Evidence for endotoxin contamination in plastic Na+-heparin blood collection tube lots.
Clin Chem
; 56(9): 1483-91, 2010 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-20663962
8.
Population Pharmacokinetics of an Anti-PD-L1 Antibody, Durvalumab in Patients with Hematologic Malignancies.
Clin Pharmacokinet
; 59(2): 217-227, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31332669
9.
Dynamic anchoring of PKA is essential during oocyte maturation.
Curr Biol
; 16(3): 321-7, 2006 Feb 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-16461287
10.
Deletion of the RIIbeta-subunit of protein kinase A decreases body weight and increases energy expenditure in the obese, leptin-deficient ob/ob mouse.
Mol Endocrinol
; 19(4): 982-91, 2005 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-15618289
11.
The Broad Anti-AML Activity of the CD33/CD3 BiTE Antibody Construct, AMG 330, Is Impacted by Disease Stage and Risk.
PLoS One
; 10(8): e0135945, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-26305211